FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention describes new derivatives of 4-cyano-4-phenylsubstituted cyclohexanes or cyclohexenes of the formula (I) where R1 means (CR4R5)r; R6, where alkyl groups can be optionally substituted with one or more halogen atoms; r = 0-6; R4 and R5 are taken independently from hydrogen atom or C1-2-alkyl; R6 means hydrogen atom or C3-6-cycloalkyl where cycloalkyl-group can be optionally substituted with 1-3 methyl groups or a single ethyl group; X means YR2; Y means O; X2 means O or NR8; X3 means hydrogen atom; X4 means: (a) or (b); X5 means H, OR8 or NR8R8; R2 is taken independently from the group consisting of -CH3 and -CH2CH3 optionally substituted with one or more halogen atoms; S = 0; R3 means CN, Z-, (5-tetrazolyl), (3- or 5-oxadiazolyl[1,2,4] ), (2-oxadiazolyl-[1,3,4]) being all heterocyclic ring systems can be optionally substituted once or more times with C1-C6-alkyl that is optionally substituted with CN; Y′ means O or S; R7 means C1-6-alkyl, optionally substituted - CN; R8 is taken independently from hydrogen atom or C1-4-alkyl; R10 means R11 where R11 means hydrogen atom or C1-4-alkyl optionally substituted with one-three fluorine atoms; R14 means hydrogen atom or R7, or their pharmaceutically acceptable salts. Invention describes also a pharmaceutical composition that inhibits activity of phosphodiesterase-IV and tumor necrosis factor based on the compound of the formula (I) and a method of inhibition of activity of phosphodiesterase-IV and tumor necrosis factor by administration of the above indicated compounds. EFFECT: new compounds indicated above as inhibitors of phosphodiesterase and tumor necrosis factor. 6 cl, 30 ex
Title |
Year |
Author |
Number |
ANTAGONISTS OF ENDOTHELIAL RECEPTORS, PHARMACEUTICAL COMPOSITION, METHOD OF SYNTHESIS, METHOD OF INHIBITION OF ENDOTHELIAL RECEPTORS |
1992 |
- Rassell Donovan Kaznz
- Dzhon Dunkan Ehlliott
- Marija Amparo Lago
- Dzhek Dejl Liber
- Kehtrin Ehlizabet Pejshoff
|
RU2125980C1 |
INDANE, DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF ANTOGONIZATION OF ENDOTHELINE RECEPTORS |
1994 |
- Rassell Donovan Kaznz
- Dzhon Dunkan Ehlliott
- Maria Amparo Lago
- Dzhek Dejl Leber
- Katrin Ehlizabet Pejshoff
|
RU2130920C1 |
NITROGEN-CONTAINING HETEROARYL DERIVATIVES |
2004 |
- Roberts Kristofer Don
- Chzhi Dun-Fan
- Griffit Ronald Konrad
|
RU2375350C2 |
DERIVATIVES OF IMIDAZOLIDINE AS INHIBITORS OF PEPTIDE DEFORMYLASE |
2003 |
- Obart Kelli M.
- Bkhat Adzhita
- Kristensen Iv Zigfrit B.
- Leber Dzhek Dehjl
- Ljao Sjanmin'
|
RU2287525C2 |
(E)-3-[2-N-BUTYL-1-{(4-CARBOXYPHENYL)-METHYL}-1H-IMIDAZOLE-5- -YL]-2-(2-THIENYL)-METHYL-2-PROPENOIC ACID METHANESULFONATE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Richard Makkallok Kinen
- Dzhozef Vajnshtok
|
RU2124513C1 |
HETEROCYCLIC COMPOUND OR ITS TAUTOMERIC FORM AND/OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PHARMACEUTICALLY ACCEPTABLE SOLVATE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD GLUCOSE LEVEL, METHOD OF TREATMENT AND/OR PROPHYLAXIS OF HYPOGLYCEMIC PATIENTS |
1993 |
- Dehvid Khej
- Dzhon Tomas Sajm
|
RU2134686C1 |
TRISUBSTITUTED IMIDAZOLES SHOWING THERAPEUTIC PROPERTIES, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1994 |
- Dzherri Leroj Adams
- Piter Vil'Jam Sheldrejk
- Timoti Frehnsiz Gallager
- Ravi Shanker Garigipati
- Pol Ehlliot Bender
- Dzheffri Charl'Z Boem
|
RU2140918C1 |
QUINOLINE DERIVATIVES AS TECHYCHININ NK RECEPTOR ANTAGONISTS |
1995 |
- Karlo Farina
- Dzhuzeppe Arnal'Do Maria Dzhardina
- Mario Grun'I
- Luka Franchesko Ravelija
|
RU2155754C2 |
CONDENSED INDOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF 5-$$$-RECEPTOR ANTAGONIST |
1993 |
- Lehrami Mehri Gaster[Gb]
- Pol Adrian Vajman[Gb]
|
RU2104279C1 |
METHOD OF EPOXIDATION OF PROCHIRAL OLEFIN |
1995 |
- Bell Dehvid
- Finnej Frantsiska
- Attrill Robin Patrik
- Miller Dehvid
- Terner Dzhillian
|
RU2204562C2 |